{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T22:09:00Z","timestamp":1788473340711,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Province Medical and Health Science and Technology Project","award":["202401060833"],"award-info":[{"award-number":["202401060833"]}]},{"name":"Science and Technology Innovation Project of Binzhou Social Development","award":["2023SHFZ033"],"award-info":[{"award-number":["2023SHFZ033"]}]},{"name":"Research Project on COVID-19 Prevention and Control of Binzhou Medical University","award":["BY2021XGFY05"],"award-info":[{"award-number":["BY2021XGFY05"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"DOI":"10.1186\/s12931-026-03513-9","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T02:27:04Z","timestamp":1769135224000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Recombinant SARS-Cov-2 spike protein S1 subunit upregulates P2\u2009\u00d7\u20097-NLRP3 leading to macrophage pyroptosis promoting acute lung injury"],"prefix":"10.1186","volume":"27","author":[{"given":"Manlu","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinglin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guogang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changjun","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichu","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"key":"3513_CR1","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.ijid.2020.01.009","volume":"91","author":"DS Hui","year":"2020","unstructured":"Hui DS, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020;91:264\u20136.","journal-title":"Int J Infect Dis"},{"key":"3513_CR2","doi-asserted-by":"publisher","first-page":"100682","DOI":"10.1016\/j.genrep.2020.100682","volume":"19","author":"RA Khailany","year":"2020","unstructured":"Khailany RA, et al. Genomic characterization of a novel SARS-CoV-2. Gene Rep. 2020;19:100682.","journal-title":"Gene Rep"},{"key":"3513_CR3","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1002\/jmv.26491","volume":"93","author":"Y Li","year":"2021","unstructured":"Li Y, et al. Clinical characteristics, cause analysis and infectivity of COVID-19 nucleic acid repositive patients: A literature review. J Med Virol. 2021;93:1288\u201395.","journal-title":"J Med Virol"},{"key":"3513_CR4","doi-asserted-by":"publisher","first-page":"386","DOI":"10.7150\/ijbs.65911","volume":"18","author":"Q Shen","year":"2022","unstructured":"Shen Q, et al. COVID-19: systemic pathology and its implications for therapy. Int J Biol Sci. 2022;18:386\u2013408.","journal-title":"Int J Biol Sci"},{"key":"3513_CR5","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1631\/jzus.B2000083","volume":"21","author":"Y Shi","year":"2020","unstructured":"Shi Y, et al. An overview of COVID-19. J Zhejiang Univ Sci B. 2020;21:343\u201360.","journal-title":"J Zhejiang Univ Sci B"},{"key":"3513_CR6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41586-020-2739-1","volume":"589","author":"Y Finkel","year":"2021","unstructured":"Finkel Y, et al. The coding capacity of SARS-CoV-2. Nature. 2021;589:125\u201330.","journal-title":"Nature"},{"key":"3513_CR7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","volume":"181","author":"AC Walls","year":"2020","unstructured":"Walls AC, et al. Structure, Function, and antigenicity of the SARS-CoV-2 Spike glycoprotein. Cell. 2020;181:281\u2013e926.","journal-title":"Cell"},{"key":"3513_CR8","doi-asserted-by":"publisher","first-page":"151682","DOI":"10.1016\/j.anndiagpath.2020.151682","volume":"51","author":"GJ Nuovo","year":"2021","unstructured":"Nuovo GJ, et al. Endothelial cell damage is the central part of COVID-19 and a mouse model induced by injection of the S1 subunit of the Spike protein. Ann Diagn Pathol. 2021;51:151682.","journal-title":"Ann Diagn Pathol"},{"key":"3513_CR9","doi-asserted-by":"crossref","unstructured":"Chiok K et al. Proinflammatory responses in SARS-CoV-2 and soluble Spike glycoprotein S1 subunit activated human macrophages. Viruses. 15, 754 (2023).","DOI":"10.3390\/v15030754"},{"key":"3513_CR10","doi-asserted-by":"publisher","first-page":"e06187","DOI":"10.1016\/j.heliyon.2021.e06187","volume":"7","author":"K Shirato","year":"2021","unstructured":"Shirato K, et al. SARS-CoV-2 Spike protein S1 subunit induces pro-inflammatory responses via toll-like receptor 4 signaling in murine and human macrophages. Heliyon. 2021;7:e06187.","journal-title":"Heliyon"},{"key":"3513_CR11","doi-asserted-by":"crossref","unstructured":"Manfredelli D, et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Spike protein S1 induces Methylglyoxal-Derived Hydroimidazolone\/Receptor for advanced glycation end products (MG-H1\/RAGE) activation to promote inflammation in human bronchial BEAS-2B cells. Int J Mol Sci. 2023;24:14868.","DOI":"10.3390\/ijms241914868"},{"key":"3513_CR12","doi-asserted-by":"publisher","first-page":"L477","DOI":"10.1152\/ajplung.00223.2021","volume":"321","author":"RML Colunga Biancatelli","year":"2021","unstructured":"Colunga Biancatelli RML, et al. The SARS-CoV-2 Spike protein subunit S1 induces COVID-19-like acute lung injury in \u039a18-hACE2 Transgenic mice and barrier dysfunction in human endothelial cells. Am J Physiol Lung Cell Mol Physiol. 2021;321:L477\u201384.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"3513_CR13","unstructured":"Zhu J et al. Acute lung injury induced by Recombinant SARS-CoV-2 Spike protein subunit S1 in mice."},{"key":"3513_CR14","doi-asserted-by":"publisher","first-page":"101781","DOI":"10.1016\/j.smim.2023.101781","volume":"69","author":"SO Vasudevan","year":"2023","unstructured":"Vasudevan SO, et al. Pyroptosis-induced inflammation and tissue damage. Semin Immunol. 2023;69:101781.","journal-title":"Semin Immunol"},{"key":"3513_CR15","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41392-021-00507-5","volume":"6","author":"P Yu","year":"2021","unstructured":"Yu P, et al. Pyroptosis: mechanisms and diseases. Signal Transduct Target Ther. 2021;6:128.","journal-title":"Signal Transduct Target Ther"},{"key":"3513_CR16","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.immuni.2013.05.016","volume":"38","author":"R Mu\u00f1oz-Planillo","year":"2013","unstructured":"Mu\u00f1oz-Planillo R, et al. K\u207a efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity. 2013;38:1142\u201353.","journal-title":"Immunity"},{"key":"3513_CR17","doi-asserted-by":"publisher","first-page":"114385","DOI":"10.1016\/j.bcp.2020.114385","volume":"187","author":"P Pelegrin","year":"2021","unstructured":"Pelegrin P. P2X7 receptor and the NLRP3 inflammasome: Partners in crime. Biochem Pharmacol. 2021;187:114385.","journal-title":"Biochem Pharmacol"},{"key":"3513_CR18","doi-asserted-by":"publisher","first-page":"4310","DOI":"10.7150\/thno.71086","volume":"12","author":"Z Rao","year":"2022","unstructured":"Rao Z, et al. Pyroptosis in inflammatory diseases and cancer. Theranostics. 2022;12:4310\u201329.","journal-title":"Theranostics"},{"key":"3513_CR19","doi-asserted-by":"publisher","first-page":"110177","DOI":"10.1016\/j.neuropharm.2024.110177","volume":"261","author":"LB Domingos","year":"2024","unstructured":"Domingos LB, et al. P2X7 receptors modulate acquisition of cue fear extinction and contextual background memory generalization in male mice. Neuropharmacology. 2024;261:110177.","journal-title":"Neuropharmacology"},{"key":"3513_CR20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.intimp.2015.04.035","volume":"27","author":"S Wang","year":"2015","unstructured":"Wang S, et al. Blockage of P2X7 attenuates acute lung injury in mice by inhibiting NLRP3 inflammasome. Int Immunopharmacol. 2015;27:38\u201345.","journal-title":"Int Immunopharmacol"},{"key":"3513_CR21","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.4049\/jimmunol.1900640","volume":"203","author":"AL Chenery","year":"2019","unstructured":"Chenery AL, et al. Inflammasome-Independent role for NLRP3 in controlling innate antihelminth immunity and tissue repair in the lung. J Immunol. 2019;203:2724\u201334.","journal-title":"J Immunol"},{"key":"3513_CR22","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1093\/cvr\/cvy252","volume":"115","author":"SM Krishnan","year":"2019","unstructured":"Krishnan SM, et al. Pharmacological Inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension. Cardiovasc Res. 2019;115:776\u201387.","journal-title":"Cardiovasc Res"},{"key":"3513_CR23","doi-asserted-by":"crossref","unstructured":"Khan S et al. SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-\u03baB pathway. Elife. 10, (2021).","DOI":"10.7554\/eLife.68563"},{"key":"3513_CR24","doi-asserted-by":"crossref","unstructured":"Albornoz EA, et al. SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through Spike protein. Mol Psychiatry. 2022;28:2878\u201393.","DOI":"10.1038\/s41380-022-01831-0"},{"key":"3513_CR25","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1158\/2326-6066.CIR-20-0123","volume":"8","author":"J Qin","year":"2020","unstructured":"Qin J, et al. Blocking P2X7-Mediated Macrophage Polarization Overcomes Treatment Resistance in Lung Cancer. Cancer Immunol Res. 2020;8:1426\u201339.","journal-title":"Cancer Immunol Res"},{"key":"3513_CR26","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12915-020-00918-w","volume":"18","author":"W Wang","year":"2020","unstructured":"Wang W, et al. Paxillin mediates ATP-induced activation of P2X7 receptor and NLRP3 inflammasome. BMC Biol. 2020;18:182.","journal-title":"BMC Biol"},{"key":"3513_CR27","doi-asserted-by":"publisher","first-page":"1270081","DOI":"10.3389\/fimmu.2023.1270081","volume":"14","author":"D L\u00e9cuyer","year":"2023","unstructured":"L\u00e9cuyer D, et al. The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection. Front Immunol. 2023;14:1270081.","journal-title":"Front Immunol"},{"key":"3513_CR28","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s11302-024-10062-7","volume":"21","author":"NC Carvalho-Barbosa","year":"2025","unstructured":"Carvalho-Barbosa NC, et al. The role of the P2X7 receptor in inactivated SARS-CoV-2-induced lung injury. Purinergic Signal. 2025;21:465\u201383.","journal-title":"Purinergic Signal"},{"key":"3513_CR29","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1146\/annurev-immunol-081022-021207","volume":"41","author":"J Fu","year":"2023","unstructured":"Fu J, et al. Structural mechanisms of NLRP3 inflammasome assembly and activation. Annu Rev Immunol. 2023;41:301\u201316.","journal-title":"Annu Rev Immunol"},{"key":"3513_CR30","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.bbi.2021.12.007","volume":"100","author":"MG Frank","year":"2022","unstructured":"Frank MG, et al. SARS-CoV-2 Spike S1 subunit induces neuroinflammatory, microglial and behavioral sickness responses: evidence of PAMP-like properties. Brain Behav Immun. 2022;100:267\u201377.","journal-title":"Brain Behav Immun"},{"key":"3513_CR31","doi-asserted-by":"publisher","first-page":"1178662","DOI":"10.3389\/fimmu.2023.1178662","volume":"14","author":"Z Dai","year":"2023","unstructured":"Dai Z, et al. Gasdermin D-mediated pyroptosis: mechanisms, diseases, and inhibitors. Front Immunol. 2023;14:1178662.","journal-title":"Front Immunol"},{"key":"3513_CR32","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497\u2013506.","journal-title":"Lancet"},{"key":"3513_CR33","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41392-023-01368-w","volume":"8","author":"S Liang","year":"2023","unstructured":"Liang S, et al. SARS-CoV-2 Spike protein induces IL-18-mediated cardiopulmonary inflammation via reduced mitophagy. Signal Transduct Target Ther. 2023;8:108.","journal-title":"Signal Transduct Target Ther"},{"key":"3513_CR34","doi-asserted-by":"crossref","unstructured":"Sefik E et al. Inflammasome activation in infected macrophages drives COVID-19 pathology. Nature. 606, 585\u2009\u2013\u200993 (2022).","DOI":"10.1038\/s41586-022-04802-1"},{"key":"3513_CR35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.immuni.2017.06.020","volume":"47","author":"F Di Virgilio","year":"2017","unstructured":"Di Virgilio F, et al. The P2X7 Receptor in Infection and Inflammation. Immunity. 2017;47:15\u201331.","journal-title":"Immunity"},{"key":"3513_CR36","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.2174\/1381612828666220713115906","volume":"28","author":"JL Batista Sim\u00f5es","year":"2022","unstructured":"Batista Sim\u00f5es JL, et al. Therapeutic Potential of P2X7 Purinergic Receptor Modulation in the Main Organs Affected by the COVID-19 Cytokine Storm. Curr Pharm Des. 2022;28:1798\u2013814.","journal-title":"Curr Pharm Des"},{"key":"3513_CR37","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1021\/acsptsci.2c00128","volume":"5","author":"GS Whitehead","year":"2022","unstructured":"Whitehead GS, et al. Effects of purinergic receptor deletion or Pharmacologic modulation on pulmonary inflammation in mice. ACS Pharmacol Transl Sci. 2022;5:973\u201384.","journal-title":"ACS Pharmacol Transl Sci"},{"key":"3513_CR38","doi-asserted-by":"crossref","unstructured":"Carvalho-Barbosa NC, et al. The role of the P2X7 receptor in inactivated SARS-CoV-2-induced lung injury. Purinergic Signal. 2025;21:465\u201383.","DOI":"10.1007\/s11302-024-10062-7"},{"key":"3513_CR39","doi-asserted-by":"publisher","first-page":"103478","DOI":"10.1016\/j.isci.2021.103478","volume":"24","author":"R Luu","year":"2021","unstructured":"Luu R, et al. Pannexin-1 channel opening is critical for COVID-19 pathogenesis. iScience. 2021;24:103478.","journal-title":"iScience"},{"key":"3513_CR40","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40659-023-00468-9","volume":"56","author":"J Prieto-Villalobos","year":"2023","unstructured":"Prieto-Villalobos J, et al. SARS-CoV-2 Spike protein S1 activates Cx43 hemichannels and disturbs intracellular Ca(2+) dynamics. Biol Res. 2023;56:56.","journal-title":"Biol Res"},{"key":"3513_CR41","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1038\/s41380-020-00965-3","volume":"26","author":"DE Ribeiro","year":"2021","unstructured":"Ribeiro DE, et al. Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology. Mol Psychiatry. 2021;26:1044\u201359.","journal-title":"Mol Psychiatry"},{"key":"3513_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06015-9","volume":"21","author":"C Dentone","year":"2021","unstructured":"Dentone C, et al. Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy. BMC Infect Dis. 2021;21:353.","journal-title":"BMC Infect Dis"},{"key":"3513_CR43","doi-asserted-by":"crossref","unstructured":"Zhou Z, et al. Heightened innate immune responses in the respiratory tract of COVID-19 patients. Cell Host Microbe. 2020;27:883\u201390.e2.","DOI":"10.1016\/j.chom.2020.04.017"},{"key":"3513_CR44","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41591-020-0901-9","volume":"26","author":"M Liao","year":"2020","unstructured":"Liao M, et al. Single-cell landscape of Bronchoalveolar immune cells in patients with COVID-19. Nat Med. 2020;26:842\u20134.","journal-title":"Nat Med"},{"key":"3513_CR45","doi-asserted-by":"publisher","first-page":"4990","DOI":"10.1111\/bph.15138","volume":"177","author":"F Di Virgilio","year":"2020","unstructured":"Di Virgilio F, et al. A rationale for targeting the P2X7 receptor in Coronavirus disease 19. Br J Pharmacol. 2020;177:4990\u20134.","journal-title":"Br J Pharmacol"},{"key":"3513_CR46","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1007\/s10753-021-01464-5","volume":"44","author":"OA Olajide","year":"2021","unstructured":"Olajide OA, et al. Induction of exaggerated cytokine production in human peripheral blood mononuclear cells by a Recombinant SARS-CoV-2 Spike glycoprotein S1 and its Inhibition by dexamethasone. Inflammation. 2021;44:1865\u201377.","journal-title":"Inflammation"},{"key":"3513_CR47","doi-asserted-by":"publisher","first-page":"621","DOI":"10.4049\/jimmunol.177.1.621","volume":"177","author":"JW Card","year":"2006","unstructured":"Card JW, et al. Gender differences in murine airway responsiveness and lipopolysaccharide-induced inflammation. J Immunol. 2006;177:621\u201330.","journal-title":"J Immunol"},{"key":"3513_CR48","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.intimp.2014.08.002","volume":"23","author":"W Chanput","year":"2014","unstructured":"Chanput W, et al. THP-1 cell line: an in vitro cell model for immune modulation approach. Int Immunopharmacol. 2014;23:37\u201345.","journal-title":"Int Immunopharmacol"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-026-03513-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03513-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03513-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T10:37:52Z","timestamp":1771324672000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12931-026-03513-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3513"],"URL":"https:\/\/doi.org\/10.1186\/s12931-026-03513-9","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"10 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal studies were performed following guidelines from the Directive 2010\/63\/EU of the European Parliament on the protection of animals used for scientific purposes. All protocols were approved by the Institutional Animal Care and Use Committee (IACUC) of Binzhou Medical University Hospital (Approval No. 20231208-14).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"76"}}